Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Nephrology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes
February 2026
A nationwide comparative study shows SGLT2 inhibitors lower long-term chronic kidney disease and acute kidney injury risk compared with GLP-1 receptor agonists.
Read more
3 Feb 2026
SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes
A nationwide comparative study shows SGLT2 inhibitors lower long-term chronic kidney disease and acute kidney injury risk compared with GLP-1 receptor agonists.
27 Jan 2026
Melatonin Improves Inflammation and Lipids in Paediatric Haemodialysis
Melatonin supplementation reduced inflammation and improved lipid profiles in children undergoing chronic haemodialysis, suggesting potential cardiovascular and antioxidant benefits.
20 Jan 2026
Plant-Based Low-Protein Diet Shows Promise in CKD Management
A preliminary study suggests a plant-based low-protein diet may improve metabolic and inflammatory parameters and help prevent malnutrition–inflammation complex syndrome in adults with CKD.
18 Jan 2026
Altered Bile Acid Profiles Linked to Advanced Chronic Kidney Disease
Altered serum and urinary bile acids were identified in patients with advanced chronic kidney disease, with specific bile acids associated with declining kidney function.
16 Jan 2026
Increasing Kidney Replacement Therapy in Central Eastern Europe
ERA Registry data show rising kidney replacement therapy incidence and prevalence across Central and Eastern Europe, with wide national variation and limited COVID-19 impact.
12 Jan 2026
Blood Inflammation Ratio Tied to Diabetic Nephropathy
Meta-analysis shows neutrophil to lymphocyte ratio is associated with higher risk and progression of diabetic nephropathy, supporting its potential use as an inflammatory biomarker in clinical practice.
11 Jan 2026
Statin Therapy and Survival in Acute Kidney Injury
In a multivariate Cox proportional hazards model, statin therapy was associated with a 52% relative reduction in the risk of death at 30 days.
9 Jan 2026
Neutrophil-to-Lymphocyte Ratio as Biomarker in Diabetic Nephropathy
39 studies involving 14 300 participants showed that patients with diabetic nephropathy had significantly elevated NLR levels compared to diabetic controls without nephropathy.
Loading posts...
1
2
3
…
22
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View